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In 1998, at the national meeting of the American Heart Association, former
United States Surgeon General David Satcher, MD, noted that in the previous
year our nation spent 425 billion medical-care dollars to treat chronic disease.
However, the per-capita expenditure for chronic disease prevention was only
$1.21 (SoRelle, 1998). A political realist, Satcher’s proposed response for
prevention then is our challenge now: Partnerships.
Who is included in those partnerships? Then-president of the American
Heart Association Martha Hill, RN, PhD, noted that AHA partnerships working
toward reduction of cardiovascular disease included the Centers for Disease
Control, the Health Care Finance Administration, the Health Employers Data
Information Set, the National Committee for Quality Assurance, the National
Heart, Lung and Blood Institute as well as corporate partners in the pharma-
ceutical and medical device industry (SoRelle, 1998). Missing from this list
was␣ agriculture and the prepared-food industry, which is both surprising and
tragic for many reasons.
I will address two surprisingly new understandings from the emerging field
of integrative medicine that deserve to be highlighted. First, food is pharma-
cologically active. Second, food’s pharmacologic activity is of significant public
concern. I will use the documented pharmacologic activities of omega-3
polyunsaturated fatty acids to draw the conclusion that now is the time for
medicine and agriculture to partner to positively affect public health.
FOOD AS MEDICINE
There is no question that Hippocrates’s injunction to consider food as medicine
is supported by modern science. Cross-cultural epidemiologic studies of disease
prevalence have revealed that risk factors for disease are, for the most part,
culturally rather than genetically determined. For example, studies of Japanese
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living outside of Japan demonstrated a two- to three-fold higher incidence of
diabetes compared to age, sex and body-mass-index matched Japanese. (Hara
et␣ al., 1994; Huang et al., 1996; Robinson et al., 1995). Likewise, the adoption
of westernized diets appears to play a very significant role in the development
of diabetes in Pima Indians (Williams et al., 2001; Ravussin et al., 1994).
There is no question that food fortification has played an important role in
promoting public health. Agriculture and the prepared-food industry deserve
much praise for their delivery of medically important therapies to the broad
public. Successes include prevention of goiter with iodized salt; rickets with
vitamin-D-fortified milk; beriberi, pellagra and anemia with B-vitamins and
Fe-enriched cereals; and neural-tube defects with folic acid. (Darnton-Hill
et␣ al., 2002)
Although the culture of medicine tends to dismiss the importance of dietary
interventions in disease management and prevention, medical research has
identified the potent role that dietary elements play, both in regulating gene
expression and in modifying inflammatory responses. These major activities
represent just some of the pharmacologic activities of foods. For this reason,
dietary supplements and foods can be considered drug therapies. As noted
by␣ Rick Kingston of the University of Minnesota College of Pharmacy, drug
therapies are “regulated and non-regulated substances or modalities that exert
a␣ pharmacologic or physiologic effect in the human body.”
Insights on the positive pharmacologic properties of food have not been lost
on practitioners of integrative medicine who prescribe dietary supplements
responsibly both for disease prevention and for treatment. Nor have insights
on␣ the negative pharmacologic activities of food been lost on lawyers who are
now equating “Big Food” with “Big Tobacco.” This has garnered much media
attention including a front-page article in the New York Times during this
conference. Newsweek magazine’s August 2002 article “Fighting ‘Big Fat’”
described the growing coalition of professionals targeting agriculture and the
processed-food industry (Tyre, 2002). The impetus appears to be the skyrocket-
ing rates of childhood obesity, hyperlipidemia, and type-2 diabetes mellitus.
These reports in the media reflect what might be called “the stick.” However,
there is a carrot. The positive spin is that agriculture and the prepared-food
industry have an important window of opportunity to positively affect public
health. There has been no better time in which to partner with medicine, and
in␣ particular with the integrative medicine community. The evidence base is
strong enough to take a more proactive stance in partnering for the public’s
health. I will use the deficiency of omega-3 polyunsaturated fatty acids in the
diets of North Americans and Europeans as an example.
OMEGA FATTY ACIDS
Fatty acids of the omega-3 and the omega-6 series are crucial components of
cell membranes and are considered essential: humans cannot synthesize them,
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only plants can. Neither can we interconvert them—our intake and the ratio of
our intake of omega-3 and omega-6 fatty acids determines their content in our
bodies. Truly, we are what we eat.
Their presence and the ratio of their presence in our cell membranes directs
three functions important to health: gene expression, inflammatory responses,
and intercellular communication. An imbalance in intake results in imbalanced
physiologic functioning and markedly increased risk of disease.
In the past 30 years, North American and European diets have seen increased
intake of omega-6 fatty acids. Vegetable oils rich in these include corn, grape-
seed, safflower and sunflower at 60 to 70%, and soy, cottonseed and sesame
at␣ 45 to 50%. Increased use of cereal-based livestock production means that
meats and many fish are now rich in omega-6 fatty acids. Processed foods rich
in omega-6 include: infant formula, margarine, mayonnaise, salad dressings,
crackers, cookies, prepared-dough products, snack foods, as well as meats
and␣ seafoods.
As meats and fish were traditionally our sources of omega-3 fatty acids, we
have experienced an unprecedented shift in the balance of these two essential
fatty acids. Omega-6 intake has skyrocketed and omega-3 intake has plum-
meted. What used to be a 2–4:1 balance has shifted to 10–25:1, as documented
in breast milk and in serum (Sanders, 2000; Simopoulos, 2001). The scientific
literature documents or supports that omega-3 deficiency, and the imbalance of
omega-6 and omega-3 fatty acids, have important negative effects in:
• coronary artery disease,
• breast and other cancers,
• post-partum depression,
• major depression and bipolar disease,
• attention-deficit disorder,
• osteoporosis,
• inflammatory arthritis, and
• inflammatory bowel disease.
The mean current intake of omega-3 fatty acids in a typical North American
diet is approximately 130 mg/day or about 0.15% of total dietary fat intake
(Kris-Etherton et al., 2000). The American Heart Association’s 2000 guidelines
recommended an omega-3 fatty acid intake of 900 mg/day based on the results
of large intervention trials that demonstrated significant benefit at that level
(Krauss et al., 2000). This means that current intake of 130 mg/day is just 14%
of the recommendation. Of note, the dietary intake of omega-3 fatty acids is
about 14 g/day in Eskimos (Feskens et al., 1993).
In this paper, I will share evidential data regarding the power of omega-3
fatty acids in cardiovascular disease. Given the interest of the American Heart
Association and others in partnering for improved cardiovascular health, there
clearly exist new opportunities for agriculture.
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OMEGA-3 AND CARDIOVASCULAR DISEASE
Mechanisms for cardioprotection from the omega-3 fatty acids include:
• reduction in malignant ventricular arythmias,
• inhibition of atherosclerosis,
• improved endothelial relaxation,
• lipid lowering, including reduction of both fasting and postprandial
triglycerides, and
• antithrombotic effects, including reduced platelet reactivity.
The positive consequences of these actions have been reflected in a large
number of studies from basic science to randomized controlled trials. Two
significant articles were published just before this conference. Albert et al.
(2002) used a nested, case-control analysis of apparently healthy men followed
for 17 years in the Physicians Health Study. The fatty-acid composition of blood
for 94 men in whom sudden cardiac death occurred as the first manifestation
of␣ cardiovascular disease was compared with that of 184 matched controls
for␣ age and smoking status. The authors documented that the base-line blood
levels of omega-3 fatty acids were inversely related to the risk for sudden
cardiac death both before and after adjustment for potential confounders.
Compared to those in the lowest quartile of omega-3 blood levels, those in
the␣ highest had an adjusted relative risk of just 0.19 (95% CI: 0.05–0.71); the
P ␣ for trend was 0.007. This is considered a very strong association with great
statistical strength. This finding is consistent with the large volume of basic
scientific research, and is also supported by other epidemiologic studies of
primary prevention both in men and in women (Hu et al., 2002).
Critics will point out that even with a well established mechanism of action
and supporting studies, correlation does not equal causality. Therefore, Bucher
et al. (2002) reviewed all of the randomized controlled intervention trials
that␣ compared intake of omega-3 fatty acids with a control diet or placebo in
patients with established coronary disease (secondary prevention): was there
a␣ positive causal effect? They identified eleven trials that included 7,951
patients in the intervention arm and 7,855 patients in the control groups.
They␣ documented that the risk ratio of a fatal myocardial infarction was
significantly reduced at 0.7 (95% CI: 0.6–0.8, P <0.001). In five trials, sudden
cardiac death was associated with a risk ratio of just 0.7 (95% CI: 0.6–0.9, P
<0.01). Consistent with the multiple effects in other disease states noted above,
including cancer, the risk ratio for overall mortality was also significantly
reduced at 0.8 (95% CI: 0.7–0.9, P <0.01) (Bucher et al., 2002).
In essence, omega-3 fatty acids appear to be both important and absent in
our␣ diet. And this represents just one natural product known and used by
integrative medicine practitioners to positively effect health states. There are




In regard to the public’s health, agriculture and the prepared-food industry
have␣ both a significant responsibility and a significant opportunity regarding
the public’s health. Sticks and carrots exist to promote innovations in health-
promoting foods; I believe in carrots. And I believe in new partnerships to
identify the best business- and best health-promoting opportunities. And,
clearly, partnerships are also needed to transform public-opinion and consumer-
purchasing patterns.
In summary, I hope I have conveyed two points: food is pharmacologically
active, and this pharmacologic activity is of great public concern. I also hope
that I have conveyed the importance of looking to the integrative medicine
community for partnerships in new-product as well as market development.
The University of Minnesota’s Center for Spirituality and Healing plus the
Center for Plants and Human Health represent two such potential partners with
expertise and interest in effecting positive change in our nation’s food supply.
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